By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Vaxon Biotech SA 

2 rue Gaston Cremieux

Evry Genopole  Cedex  91057  France
Phone: 33-0-160789210 Fax: 33-0-160789219


Company News
Vaxon Biotech SA Publishes Article Supporting Potential Of Proprietary Optimized Cryptic Peptides As "Universal Neoantigens" 6/20/2016 10:50:50 AM
Vaxon Biotech SA Completes Enrollment Of Phase 2b Lung Cancer Trial Of First Therapeutic Vaccine Based On Optimized Cryptic Peptides 3/16/2016 9:16:09 AM
Vaxon Biotech SA Granted Japanese Patent For New Cancer Vaccine Candidates 6/22/2015 9:44:13 AM
Vaxon Biotech SA Appoints Founder And Chief Scientific Officer, Dr. Konstantinos Kosmatopoulos, As CEO 3/30/2015 9:15:48 AM
Vaxon Biotech SA Successfully Completes Its Phase I/II Trial Of Vx-001 Cancer Vaccine, Phase III Ready To Start In NSCLC 5/19/2010 11:37:46 AM
Vaxon Biotech SA Receives European Orphan Medicinal Product Designation for Vx-001 11/16/2007 11:45:19 AM
Genopole(R) And Six Of Its Campus Companies Will Attend The International Biotechnology Industry Organization (BIO) 2006 Trade Show 4/5/2006 10:47:15 AM
Vaxon-Biotech Announces Phase I Study Results for VX-001 Immunotherapy In Cancer Patients10/19/2005 5:12:24 PM